0
Pluristem Therapeutics, Inc. Banner Image

Pluristem Therapeutics, Inc. has reached its limit for free report views

Work for Pluristem Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Pluristem Therapeutics, Inc.

  • Ticker PSTI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Pluristem Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Haifa, Israel
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late stage clinical trials in several indications. PLX cell product candidates are believed to release aMore range of therapeutic proteins in response to inflammation, ischemia, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients offthe-shelf, without tissue matching. Pluristem has a strong intellectual property position; a Company-owned and operated GMP-certified manufacturing and research facility; strategic relationships with major research institutions; and a seasoned management team.
Pluristem Therapeutics, Inc.

Most Recent Annual Report

Pluristem Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Pluristem Therapeutics, Inc. has reached its limit for free report views.